Key Insights

Highlights

Success Rate

88% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

5.6%

1 terminated out of 18 trials

Success Rate

87.5%

+1.0% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 7 completed with results

Key Signals

88% success

Data Visualizations

Phase Distribution

13Total
Not Applicable (8)
Early P 1 (1)
P 1 (2)
P 2 (2)

Trial Status

Completed7
Unknown6
Withdrawn3
Terminated1
Not Yet Recruiting1

Trial Success Rate

87.5%

Benchmark: 86.5%

Based on 7 completed trials

Clinical Trials (18)

Showing 18 of 18 trials
NCT02310542Not ApplicableCompletedPrimary

Comparison of Two Liver Dialysis Systems : MARS Versus SPAD in Severe Liver Failure

NCT06263114Terminated

Correlation of Blood Gene Expression (TruGraf Liver) With Liver Biopsy in Pediatric Liver Transplant Recipients

NCT05817994Withdrawn

Endoscopic Ultrasound Guided Liver Biopsy and Portal Pressure Registry

NCT05473403Not ApplicableNot Yet RecruitingPrimary

Validation of a Prognostic Score for Steroid Therapy Response in Acute Severe Autoimmune Hepatitis

NCT05778461Not ApplicableUnknownPrimary

Efficacy of L-ornithine L-aspartate and Therapeutic Plasma Exchange Versus Plasma Exchange Alone in Lowering Ammonia and Improving Outcomes in Pediatric Acute Liver Failure.

NCT04959110Not ApplicableCompleted

Citrate Pharmacokinetics in Critically Ill Liver Failure Patients Receiving CRRT

NCT03312036Not ApplicableCompletedPrimary

HEpatic Regeneration With COupled Plasma Filtration and Adsorption for Liver Extracorporeal Detoxification

NCT04512014CompletedPrimary

Perioperative Lactate Kinetics in Patient Undergoing Major Liver Surgery

NCT02687763Early Phase 1Completed

Safety and Efficacy of ProQuad® in Children 6-24 Month Being Evaluated for Solid Organ Transplant

NCT01345565Phase 1WithdrawnPrimary

Hepatocyte Transplantation for Acute Decompensated Liver Failure

NCT03084198Not ApplicableUnknownPrimary

Safety and Efficacy of hiHep Bioartificial Liver Support System to Treat Acute Liver Failure

NCT01137591Not ApplicableWithdrawn

Acetaminophen in Combination With N-Acetylcysteine (NAC) Versus Placebo in Treating Fever

NCT01878305CompletedPrimary

Neuromonitoring of Hepatic Encephalopathy

NCT01394497Phase 2Completed

Use of N-Acetylcysteine During Liver Procurement

NCT01471262Unknown

Right Hepatectomy in Patients Beyond 70 Years Old

NCT01341951Not ApplicableUnknownPrimary

Granulocyte Colony Stimulating Factor (G-CSF) in Acute Liver Failure and Alcoholic Hepatitis

NCT01318525Phase 2UnknownPrimary

Efficacy & Safety of ALF-5755 in Patients With Nonacetaminophen Severe Acute Hepatitis & Early Stage Acute Liver Failure

NCT00225901Phase 1UnknownPrimary

Phase I/II Study of Recombinant Human Hepatocyte Growth Factor in Fulminant Hepatic Failure

Showing all 18 trials

Research Network

Activity Timeline